多囊卵巢综合征与健康女性妊娠晚期凝血及纤溶系统比较

Coagulation and fbrinolytic system features in patients with polycystic ovary syndrome and healthy women at the third trimester of pregnancy

  • 摘要: 目的 比较多囊卵巢综合征(polycystic ovary syndrome,PCOS)患者与健康女性妊娠晚期凝血和纤溶系统特征。 方法 收集2012年4月-2013年3月海军总医院产科门诊常规产检的孕妇,分为PCOS妊娠组与正常妊娠组,每组各40例,分别测定妊娠晚期(≥37周)凝血与纤溶系统相关指标。 结果 与正常妊娠组相比,凝血因子Ⅷ(FⅧ)、凝血因子Ⅹ(FⅩ)、血友病因子(vWF)、D-D二聚体和纤溶酶原活化剂抑制物(PAI-1)在PCOS妊娠组明显升高(P< 0.05),组织型纤溶酶原活化剂(t-PA)明显降低(P< 0.05)。 结论 与正常妊娠晚期相比,PCOS患者血液表现为更加高凝和低纤溶的状态。

     

    Abstract: Objective To compare the coagulation and fibrinolytic system features in patients with polycystic ovary syndrome (PCOS) and healthy women at the third trimester of pregnancy. Methods Eighty pregnant women who underwent routine obstetric examination in Outpatient Department of Obstetrics and Gynecology of Navy General Hospital from April 2012 to March 2013 were divided into PCOS group and normal pregnant group (40 in each group). Their coagulation and fbrinolytic system markers at the third trimester of pregnancy (≥ 37 weeks) were detected. Results The activity of coagulation factor Ⅷ (FⅧ) and coagulation factorⅩ (FⅩ) and the levels of von Willebrand factor (vWF), plasminogen activator inhibitor 1(PAI-1) and D-dimer were significantly higher while the tissue plasminogen activator (t-PA) level was significantly lower in PCOS group than in normal pregnant group (P< 0.05). Conclusion The level of coagulation is signifcantly higher while the levels of fbrinolytic system markers are signifcantly lower in PCOS patients than in healthy women at the third trimester of pregnancy.

     

/

返回文章
返回